- Home
- NBIX vs BJ Comparison
NBIX vs BJ Comparison
Compare NBIX & BJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NBIX | BJ |
|---|---|---|
| Founded | 1992 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Department/Specialty Retail Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.9B | 12.9B |
| IPO Year | 1996 | 2018 |
Fundamental Metrics
Financial Performance| Metric | NBIX | BJ |
|---|---|---|
| Price | $128.55 | $98.07 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 22 | 15 |
| Target Price | ★ $175.23 | $108.36 |
| AVG Volume (30 Days) | 1.2M | ★ 1.7M |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 41.95 | 3.09 |
| EPS | ★ 4.67 | 3.42 |
| Revenue | $161,626,000.00 | ★ $20,501,804,000.00 |
| Revenue This Year | $22.85 | $9.10 |
| Revenue Next Year | $9.99 | $6.71 |
| P/E Ratio | $27.75 | ★ $27.40 |
| Revenue Growth | ★ 977.51 | 2.67 |
| 52 Week Low | $84.23 | $86.68 |
| 52 Week High | $160.18 | $121.10 |
Technical Indicators
Market Signals| Indicator | NBIX | BJ |
|---|---|---|
| Relative Strength Index (RSI) | 42.79 | 52.15 |
| Support Level | $122.82 | $94.23 |
| Resistance Level | $128.99 | $100.33 |
| Average True Range (ATR) | 2.97 | 3.25 |
| MACD | 0.12 | -0.50 |
| Stochastic Oscillator | 23.91 | 63.97 |
Price Performance
Historical ComparisonAbout NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About BJ BJ's Wholesale Club Holdings Inc.
BJ's Wholesale Club, founded in 1984, operates a membership-based warehouse club model primarily along the US East Coast, with roughly 250 clubs and a growing domestic presence across 21 states. In fiscal 2024, the company generated over $20 billion in revenue. BJ's offers a value-oriented assortment skewed toward grocery, perishables, and consumables (71% of sales), general merchandise (11%), and gasoline (18%). Its business model is supported by recurring membership fee income and private-label brands such as Wellsley Farms and Berkley Jensen.